SightfileU.S. market data from official filings

GSK PLC (GSK)

Name: GSK PLC (GSK) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001131399 · EDGAR filings · Updated 2026-07-28

GSK PLC (GSK) has reported institutional ownership of 8.7%, with 1,023 institutional managers holding positions valued at $20.7B per the latest 13F reporting period.

Institutional ownership

8.7%

Institutional managers

1,023

Reported 13F value

$20.7B

Filings this week (6)

2026-07-28 — Foreign issuer report (6-K) filed
2026-07-28 — Foreign issuer report (6-K) filed
2026-07-28 — Foreign issuer report (6-K) filed
2026-07-24 — Foreign issuer report (6-K) filed
2026-07-24 — Foreign issuer report (6-K) filed
2026-07-22 — Foreign issuer report (6-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-20 — Foreign issuer report (6-K) filed
2026-07-17 — Foreign issuer report (6-K) filed
2026-07-17 — Foreign issuer report (6-K) filed
2026-07-16 — Foreign issuer report (6-K) filed
2026-07-15 — Foreign issuer report (6-K) filed
2026-07-15 — SC TO-T/A filed
2026-07-14 — Foreign issuer report (6-K) filed
2026-07-13 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, GSK PLC has 1,023 institutional holders and institutional ownership of 8.7%.

#	Institution	Reported value	% of tracked total
1	FMR LLC	$3.73B	18.1%
2	Dodge & Cox	$3.24B	15.7%
3	Fisher Asset Management, LLC	$1.91B	9.2%
4	PRIMECAP MANAGEMENT CO/CA/	$1.39B	6.7%
5	ACADIAN ASSET MANAGEMENT LLC	$651.0M	3.2%
6	WELLINGTON MANAGEMENT GROUP LLP	$646.7M	3.1%
7	MORGAN STANLEY	$608.8M	2.9%
8	GOLDMAN SACHS GROUP INC	$529.2M	2.6%
9	JTC Employer Solutions Trustee Ltd	$498.9M	2.4%
10	ROYAL BANK OF CANADA	$414.3M	2.0%

Full holder history and quarter-over-quarter changes are available inside the app.

Fails-to-deliver

The SEC's fails-to-deliver file for 2026-06-30 reports 55,098 failed-to-deliver shares ($2.27M) for GSK — an official data point published by the SEC, shown as reported.

Related companies

ARGENX SE (ARGX) · STERIS PLC (STE) · LABCORP HOLDINGS INC (LH) · QUEST DIAGNOSTICS INC (DGX) · ILLUMINA INC (ILMN) · REVOLUTION MEDICINES INC (RVMD)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.